CN117715661A - 用于nirf成像的普地沙铵 - Google Patents

用于nirf成像的普地沙铵 Download PDF

Info

Publication number
CN117715661A
CN117715661A CN202280052692.7A CN202280052692A CN117715661A CN 117715661 A CN117715661 A CN 117715661A CN 202280052692 A CN202280052692 A CN 202280052692A CN 117715661 A CN117715661 A CN 117715661A
Authority
CN
China
Prior art keywords
dose
free form
pharmaceutical composition
urine
prixaammonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280052692.7A
Other languages
English (en)
Chinese (zh)
Inventor
齐藤正子
小松完尔
田草川伸
莱蒂西亚·德尔加多-赫雷拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of CN117715661A publication Critical patent/CN117715661A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202280052692.7A 2021-07-28 2022-07-27 用于nirf成像的普地沙铵 Pending CN117715661A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163226534P 2021-07-28 2021-07-28
US63/226,534 2021-07-28
PCT/IB2022/056957 WO2023007404A1 (en) 2021-07-28 2022-07-27 Pudexacianinium for nirf imaging

Publications (1)

Publication Number Publication Date
CN117715661A true CN117715661A (zh) 2024-03-15

Family

ID=82898903

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280052692.7A Pending CN117715661A (zh) 2021-07-28 2022-07-27 用于nirf成像的普地沙铵

Country Status (9)

Country Link
US (1) US20240342316A1 (https=)
EP (1) EP4376896A1 (https=)
JP (1) JP2024527715A (https=)
KR (1) KR20240041952A (https=)
CN (1) CN117715661A (https=)
AU (1) AU2022321011A1 (https=)
CA (1) CA3226034A1 (https=)
MX (1) MX2024001242A (https=)
WO (1) WO2023007404A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4605020A1 (en) * 2022-10-21 2025-08-27 Astellas Pharma, Inc. Composition for near infrared lymphatic imaging and uses and dosages therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE041616T2 (hu) 2010-01-28 2019-05-28 National Univ Corporation Mie Univ Indocianin vegyület, szintézisének eljárása, tisztítási eljárása, indocianin vegyületet alkalmazó diagnosztikai készítmény, és készülék in vivo kinetika mérésére és készülék keringés megjelenítésére a diagnosztikai készítmény alkalmazásával

Also Published As

Publication number Publication date
CA3226034A1 (en) 2023-02-02
US20240342316A1 (en) 2024-10-17
KR20240041952A (ko) 2024-04-01
WO2023007404A1 (en) 2023-02-02
MX2024001242A (es) 2024-02-13
AU2022321011A1 (en) 2024-01-25
EP4376896A1 (en) 2024-06-05
JP2024527715A (ja) 2024-07-26

Similar Documents

Publication Publication Date Title
EP3538070B1 (en) Pharmaceutical composition of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma
DK3154551T3 (en) APPLICATION OF DEXTRANSULPHATE WITH A MEDIUM MOLECULAR WEIGHT UNDER 10,000 EN TO INJECT ANGIOGENES OF AN INDIVIDUAL
Murase et al. Randomized, double‐blind, controlled study to evaluate safety and pharmacokinetics of single ascending doses of ASP5354, an investigational imaging product, in healthy adult volunteers
RU2615767C2 (ru) Способ лечения сердечной недостаточности и поражения нервных клеток
JP5211073B2 (ja) 子宮内膜症の治療用の薬剤
CN117715661A (zh) 用于nirf成像的普地沙铵
US20190275053A1 (en) Method of treating pain in elderly patients with mild renal impairment
EP0617964B1 (en) Injection for curing injured abnormal tissue, process for producing the same, and use thereof
WO2015190989A1 (en) The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject
HK40104552A (zh) 用於nirf成像的普地沙铵
Jana et al. Isolated renal hydatic cyst in the primary generation of the larvocyst
JP3714972B2 (ja) 病変組織異常血管の注射用止血剤
Bilici et al. The treatment of lymphangiomas with bleomycin in childhood: A retrospective observational study
US20100266501A1 (en) Methods and compositions for organ protection
CN116492447A (zh) Foxm1在制备治疗缺血性心脏病药物中的应用
CN115845088A (zh) 一种亚甲蓝纳米颗粒、制备方法及其应用
Jun et al. Unexpected Intraocular Inflammation Following the Use of Anti-Adhesion Agents, Mediclore®-A Case Report
WO2025242174A1 (zh) 用于治疗结缔组织病的化合物及其药物组合物
HK40105798A (zh) 用於治疗脑梗塞的药物组合物
CN121534039A (zh) 一种含巴西苏木素的药物组合物及其制备方法和应用
AU2023316786A1 (en) Imatinib formulation for parenteral administration
HK40122833A (zh) 组织蛋白酶d抑制剂在制备预防或治疗骨关节炎的药物中的应用
HK40009453A (en) Pharmaceutical composition of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma
HK40009453B (en) Pharmaceutical composition of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma
Imbelloni et al. Vieira AdV, e Gonçalves PMS, Lopes LM (2022) Intradural And Intramedullary Melanotic Schwannoma Of The Lumbar Spine, After Spinal Anesthesia

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40104552

Country of ref document: HK

SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination